Ponatinib induced improvement of cutaneous lesions associated to accelerated phase of Ph-positive chronic myeloid leukemia. Mediterranean Journal of Hematology and Infectious Diseases, [S. l.], v. 8, p. e2016016, 2016. DOI: 10.4084/mjhid.2016.016. Disponível em: https://www.mjhid.org/mjhid/article/view/2016.016. Acesso em: 2 may. 2026.